Cite
MLA Citation
Anna Dalla Pietà et al.. “Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells.” Journal for immunotherapy of cancer, vol. 9, no. 7, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100135136492.0x000004